MultiCell Technologies Inc.
68 Cumberland Street
Suite 301
Woonsocket
Rhode Island
02895
United States
Tel: 401-762-0045
Fax: 401-762- 0098
Website: http://www.multicelltech.com/
84 articles about MultiCell Technologies Inc.
-
MultiCell Technologies Inc. Files Novel Antibody-Drug Conjugate Patent Application
12/10/2014
-
MultiCell Technologies Inc. Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer
8/25/2014
-
MultiCell Technologies Inc. Files U.S. And International Patent Applications For The Treatment Of Liver Cancer
3/21/2014
-
MultiCell Technologies Inc. Files Patent Application Covering New Class Of RNA Therapeutics
1/15/2014
-
MultiCell Technologies Inc. Files U.S. Patent Application For Targeted Delivery Of MCT-485, A Noncoding miRNA For Cancer Treatment
11/13/2013
-
MultiCell Technologies Inc. Expands Scope of Research Agreement for the Treatment of Liver Cancer
10/2/2013
-
MultiCell Technologies Inc. and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
8/6/2013
-
MultiCell Technologies Inc. Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
5/16/2013
-
MultiCell Technologies Inc. Delivered Presentation at 2012 ASCB Meeting
12/27/2012
-
Grant G. Miller Joins Board of MultiCell Technologies Inc.
10/23/2012
-
MultiCell Technologies Inc. to Announce Positive Preclinical Results at 2012 American Society for Cell Biology Meeting
9/27/2012
-
Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies Inc.
9/6/2012
-
MultiCell Technologies Inc. Announces Results of Shareholders' Meeting
8/15/2012
-
MultiCell Technologies Inc. Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in Vitro Models
8/10/2012
-
MultiCell Technologies Inc. Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in Vitro Models
5/16/2012
-
MultiCell Technologies Inc. Receives Final Payment Under QTDP Program
1/3/2012
-
MultiCell Technologies Inc. and University Health Network Will Evaluate Two Potential Therapies for Liver Cancer Treatment
7/11/2011
-
MultiCell Technologies Inc. is Granted Stem Cell Patent
5/31/2011
-
Xenogenics Retains the Emmes Group to Advise on Fund Raising Efforts
2/23/2011
-
MultiCell Technologies Inc. Receives $733,437 Cash Grant Award Under U.S. Government's Qualifying Therapeutic Discovery Project Program
11/2/2010